H.R. 9635 (119th)Passage Likelihood

To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations

domestic policy
Cosponsors
Support
Democratic
Introduced
Jul 9, 2026
Discussions
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Loading passage likelihood analysis...